Navigation Links
Medivation's Dimebon(TM) Significantly Improved Daily Function in Alzheimer's Disease Patients, Resulting in Reduced Need for Caregiver Assistance
Date:4/15/2008

molecule that has been shown to inhibit brain cell death in preclinical models relevant to Alzheimer's and Huntington's diseases, making it a potential treatment for these and other neurodegenerative diseases.

About Medivation

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three large, unmet medical needs -- Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. The Company's strategy is to identify promising product candidates, to develop them in a rapid, cost-effective manner, and to seek development and/or commercialization partners as appropriate to complement its internal efforts. For more information, please go to http://www.medivation.com.

This press release contains forward-looking statements, including statements regarding anticipated clinical and regulatory milestones, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. None of the Company's product candidates has been approved for sale, significant additional animal and human testing is required in order to seek marketing approval for any of its product candidates, and Medivation cannot assure you that marketing approval can be obtained for any of its product candidates. Furthermore, as is typically the case at this stage of the regulatory review process, the FDA has not yet performed an in-depth review of Medivation's preclinical and clinical data, so its views remain subject to change. Medivation's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31,
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
2. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
5. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
6. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
7. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
8. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
9. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
10. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
11. Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015   Mallinckrodt plc (NYSE: MNK ), ... 13, 2015, at the Bank of America Merrill Lynch 2015 ... Las Vegas, Nev. ... Officer, and Cole Lannum , Senior Vice President of ... in a session scheduled to begin at 3 p.m. Eastern ...
(Date:5/4/2015)... Colo., May 4, 2015  Array BioPharma Inc. ... the third quarter of its fiscal year ending ... Executive Officer of Array, noted, "With the close of ... and encorafenib, two innovative oncology products in Phase ... product in 2016. These transformative transactions have accelerated ...
(Date:5/4/2015)... HAVEN, Conn. , May 4, 2015 /PRNewswire/ ... chosen by the American Optometric Association (AOA) to ... delivery and outcomes for the millions of patients ... Measures and Outcomes Registry for Eyecare (MORE) ... will securely facilitate efficient secondary uses of essential ...
Breaking Medicine Technology:Mallinckrodt To Present At Bank Of America Merrill Lynch 2015 Health Care Conference 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 10American Optometric Association, Prometheus Research to Create Transformative Health Outcomes Registry 2
(Date:5/4/2015)... DC (PRWEB) May 04, 2015 ... has just released the first-ever congenital heart ... Cardiac Catheterization Laboratory (PCCL) accreditation. Driven by ... standards are a comprehensive review of interventional ... congenital heart disease. , “The ACE CHD ...
(Date:5/4/2015)... Sara Soulati, CEO of Global Cardio ... Los Angeles associated with the field of Enhanced External ... Sara Soulati Health For Life Program (SSHFLP). , The ... modification and disease prevention program. A provisional patent ... Patents and Trademarks Office and is now under review ...
(Date:5/3/2015)... ANGELES, American Telemedicine Association 2015 Meeting & Tradeshow ... e-health solutions, a full-service telemedicine and mobile health ... new platform, VITA health services for chronic disease ... services platform enables remote patient monitoring of a ... heart failure (CHF), diabetes, COPD, hypertension and other ...
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch ... latest and coolest technology products available to consumers. Scott Steinberg, ... review and shared with viewers how to protect their private ... is on computers and even more so online. It helps ... all over the world. In terms of work, the internet ...
(Date:5/3/2015)... It is not too late to register to take part ... Lissa Anne Been in Arnold, Missouri on May 9, 2015. ... honor her loving memory. It has benefited the renowned Brain Aneurysm ... 37, Lissa suffered a brain aneurysm . After two operations ... event is designed to serve as a remembrance of her and ...
Breaking Medicine News(10 mins):Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 3Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2
... not invincible but its weaknesses can be difficult to detect. ... Greek warrior whose one vulnerability led to his undoing ... weak spots. In their largest and most comprehensive effort to ... and the Dana-Farber Cancer Institute examined cells from over 100 ...
... University College of Engineering student, has received the 2011 ... program financially supports scientific studies that investigate and aim ... a Ph.D. student under the supervision of Sean Wu, ... is developing an innovative, 3-D computer-aided diagnostic system to ...
... CITY One-fifth of all patients with pulmonary arterial ... two years before being correctly diagnosed and properly treated, ... at Intermountain Medical Center in Salt Lake City. ... is more difficult and the damage is irreversible," said ...
... stroke Stroke is a leading cause of long-term ... researchers led by Gregory Bix, at Texas A&M College ... exploit one of the brain,s self-repair mechanisms to protect nerve ... The authors suggest that this approach could provide a nontoxic ...
... changes in the structure of DNA so-called epigenetic ... cells, according to one of two studies conducted by ... Cancer Institute. Together with collaborators from a biotechnology company, ... that blocks these changes could deactivate cancer-promoting genes and ...
... are physically active and eat plenty of vegetables but few ... study led by researchers at the Keck School of Medicine ... published in the July 2011 issue of the American ... to examine how weight among Chinese adolescents relates to factors ...
Cached Medicine News:Health News:Project Achilles pinpoints vulnerabilities in ovarian cancer 2Health News:Project Achilles pinpoints vulnerabilities in ovarian cancer 3Health News:New study may lead to quicker diagnosis, improved treatment for fatal lung disease 2Health News:JCI online early table of contents: July 11, 2011 2Health News:JCI online early table of contents: July 11, 2011 3Health News:JCI online early table of contents: July 11, 2011 4Health News:JCI online early table of contents: July 11, 2011 5Health News:JCI online early table of contents: July 11, 2011 6Health News:JCI online early table of contents: July 11, 2011 7Health News:JCI online early table of contents: July 11, 2011 8Health News:Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer 2Health News:Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer 3Health News:'Healthy' habits linked to childhood obesity in China 2Health News:'Healthy' habits linked to childhood obesity in China 3
... The next generation Powerheart AED has ... our flagship, feature-rich AED offering. The ... new customer-friendly features such as more ... new lighter weight, redesigned form factor, ...
... Plus™ is the best EMR value for ... in mind, Charting Plus™ relies heavily on ... features to improve documentation quality and increase ... content is specific to your medical specialty. ...
... the vast information needs of orthopedics specialty. ... for common orthopedics complaints, history of present ... also includes orthopedics specific ICD and CPT ... charges and quickly generate electronic Superbill at ...
... Maximo, Model 7303, incorporates new advances in CRT ... Proven Marquis ICD Platform. With this device, ... in 9 seconds or less throughout the life ... (14% increase in longevity over InSync II Marquis) ...
Medicine Products: